The systemic administration of an AAV8 encoding miR-26a, which is highly downregulated in hepatocellular cancer and induces cell cycle arrest by targeting the cyclins D2 and E2, resulted in inhibition of cancer cell proliferation, induction of tumor-specific apoptosis and significant tumor regression, without toxicity [140]. This evidence concerns the gene CCND2 and neoplasm.